Evidence map›Paper›PMID 21176905›Full record

ArticleAtherosclerosis2011

Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.

Ivy A Ku, Ramin Farzaneh-Far, Eric Vittinghoff, Mary H Zhang, Beeya Na, Mary A Whooley

Abstract readMulticenter Study
In one paragraph

Article in Atherosclerosis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ivy A KuDepartment of Medicine, University of California, San Francisco, CA, USA. ivy.ku@ucsf.edu
Ramin Farzaneh-Far
Eric Vittinghoff
Mary H Zhang
Beeya Na
Mary A Whooley
University of California, San Francisco · USMassachusetts General Hospital · USSan Francisco VA Medical Center · US

Funding

Epidemiology of Depression and Heart Failure in AgingR01HL079235 · NHLBI · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WHOOLEY, MARY A · 2005 to 2009
$4.2M
Inflammation and Atherosclerosis in Rheumatoid ArthritisF32HL097461 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, IVY ANN · 2009 to 2010
$122k
NHLBI NIH HHS F32 HL097461NHLBI NIH HHS HL097461NHLBI NIH HHS R01 HL079235
6 · The paper itself

Abstract

objectiveLeptin is an adipokine with both protective and harmful effects on the cardiovascular (CV) system. Prior studies evaluating the association between leptin and CV outcomes have yielded conflicting results. Thus, we sought to investigate the relationship between leptin and CV events and mortality in patients with chronic stable coronary artery disease (CAD).

methodsWe performed a prospective cohort study of 981 outpatients with stable CAD. Leptin levels were measured in fasting venous samples at baseline. We used proportional hazards models to evaluate the association of baseline leptin with subsequent CV events (myocardial infarction, stroke, transient ischemic attack) and death.

resultsDuring a mean follow-up of 6.2±2.1 years, there were 304 deaths, 112 myocardial infarctions, and 52 strokes/TIAs. In models adjusted for age, sex, and race, low leptin was associated with a 30% increased risk of the combined outcome (HR 1.30, CI 1.05-1.59, p=0.01). After further adjustment for obesity, traditional CV risk factors and biomarkers, low leptin remained associated with a 37% increased risk of events (HR 1.37, CI 1.06-1.76, p=0.02).

conclusionsLow leptin is associated with increased CV events and mortality in patients with stable coronary artery disease. This association is independent of known factors affecting leptin levels, including gender and obesity.

Indexed as

AgedBiomarkersCardiovascular DiseasesChi-Square DistributionChronic DiseaseCoronary Artery DiseaseDown-RegulationFemaleHumansIschemic Attack, TransientKaplan-Meier EstimateLeptinMaleMiddle AgedMyocardial InfarctionProportional Hazards ModelsBiomarkersLeptin

Identifiers

PMID21176905
PMCPMC3085109
OpenAlexW1998698245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.